Tanshinone IIA improves contextual fear- and anxiety-like behaviors in mice via the CREB/BDNF/TrkB signaling pathway. 2022

Yong-Li Jiang, and Xin-Shang Wang, and Xu-Bo Li, and An Liu, and Qing-Yu Fan, and Le Yang, and Ban Feng, and Kun Zhang, and Liang Lu, and Jing-Yu Qi, and Fan Yang, and Da-Ke Song, and Yu-Mei Wu, and Ming-Gao Zhao, and Shui-Bing Liu
Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Posttraumatic stress disorder (PTSD) is one of the most common psychiatric diseases, which is characterized by the typical symptoms such as re-experience, avoidance, and hyperarousal. However, there are few drugs for PTSD treatment. In this study, conditioned fear and single-prolonged stress were employed to establish PTSD mouse model, and we investigated the effects of Tanshinone IIA (TanIIA), a natural product isolated from traditional Chinese herbal Salvia miltiorrhiza, as well as the underlying mechanisms in mice. The results showed that the double stress exposure induced obvious PTSD-like symptoms, and TanIIA administration significantly decreased freezing time in contextual fear test and relieved anxiety-like behavior in open field and elevated plus maze tests. Moreover, TanIIA increased the spine density and upregulated synaptic plasticity-related proteins as well as activated CREB/BDNF/TrkB signaling pathway in the hippocampus. Blockage of CREB remarkably abolished the effects of TanIIA in PTSD model mice and reversed the upregulations of p-CREB, BDNF, TrkB, and synaptic plasticity-related protein induced by TanIIA. The molecular docking simulation indicated that TanIIA could interact with the CREB-binding protein. These findings indicate that TanIIA ameliorates PTSD-like behaviors in mice by activating the CREB/BDNF/TrkB pathway, which provides a basis for PTSD treatment.

UI MeSH Term Description Entries
D005239 Fear The affective response to an actual current external danger which subsides with the elimination of the threatening condition. Threat Cues,Threat Sensitivity,Cue, Threat,Fears,Sensitivity, Threat,Threat Cue,Threat Sensitivities
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001007 Anxiety Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS. Angst,Anxiousness,Hypervigilance,Nervousness,Social Anxiety,Anxieties, Social,Anxiety, Social,Social Anxieties
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D045784 Abietanes A subclass of cyclical DITERPENES that contain the abietane ring structure. Abietane Diterpene,Abietane Diterpenoid,Abietane Diterpenoids,Diterpenes, Abietane,Isopimarane,Isopimaranes,Totarane Diterpene,Totarane Diterpenes,Totaranes,Diterpenes, Pimarane,Pimaranes,Abietane Diterpenes,Diterpene, Abietane,Diterpene, Totarane,Diterpenoid, Abietane,Pimarane Diterpenes
D050882 CREB-Binding Protein A member of the p300-CBP transcription factor family that was initially identified as a binding partner for CAMP RESPONSE ELEMENT-BINDING PROTEIN. Mutations in CREB-binding protein are associated with RUBINSTEIN-TAYBI SYNDROME. Nuclear Protein CBP,Phospho-CREB-Binding Protein,CBP, Nuclear Protein,CREB Binding Protein,Phospho CREB Binding Protein
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Yong-Li Jiang, and Xin-Shang Wang, and Xu-Bo Li, and An Liu, and Qing-Yu Fan, and Le Yang, and Ban Feng, and Kun Zhang, and Liang Lu, and Jing-Yu Qi, and Fan Yang, and Da-Ke Song, and Yu-Mei Wu, and Ming-Gao Zhao, and Shui-Bing Liu
March 2020, Neuroscience,
Yong-Li Jiang, and Xin-Shang Wang, and Xu-Bo Li, and An Liu, and Qing-Yu Fan, and Le Yang, and Ban Feng, and Kun Zhang, and Liang Lu, and Jing-Yu Qi, and Fan Yang, and Da-Ke Song, and Yu-Mei Wu, and Ming-Gao Zhao, and Shui-Bing Liu
June 2024, Behavioural brain research,
Yong-Li Jiang, and Xin-Shang Wang, and Xu-Bo Li, and An Liu, and Qing-Yu Fan, and Le Yang, and Ban Feng, and Kun Zhang, and Liang Lu, and Jing-Yu Qi, and Fan Yang, and Da-Ke Song, and Yu-Mei Wu, and Ming-Gao Zhao, and Shui-Bing Liu
May 2014, Pharmacology, biochemistry, and behavior,
Yong-Li Jiang, and Xin-Shang Wang, and Xu-Bo Li, and An Liu, and Qing-Yu Fan, and Le Yang, and Ban Feng, and Kun Zhang, and Liang Lu, and Jing-Yu Qi, and Fan Yang, and Da-Ke Song, and Yu-Mei Wu, and Ming-Gao Zhao, and Shui-Bing Liu
September 2016, Psychiatry research,
Yong-Li Jiang, and Xin-Shang Wang, and Xu-Bo Li, and An Liu, and Qing-Yu Fan, and Le Yang, and Ban Feng, and Kun Zhang, and Liang Lu, and Jing-Yu Qi, and Fan Yang, and Da-Ke Song, and Yu-Mei Wu, and Ming-Gao Zhao, and Shui-Bing Liu
November 2020, International journal of molecular sciences,
Yong-Li Jiang, and Xin-Shang Wang, and Xu-Bo Li, and An Liu, and Qing-Yu Fan, and Le Yang, and Ban Feng, and Kun Zhang, and Liang Lu, and Jing-Yu Qi, and Fan Yang, and Da-Ke Song, and Yu-Mei Wu, and Ming-Gao Zhao, and Shui-Bing Liu
October 2021, Phytotherapy research : PTR,
Yong-Li Jiang, and Xin-Shang Wang, and Xu-Bo Li, and An Liu, and Qing-Yu Fan, and Le Yang, and Ban Feng, and Kun Zhang, and Liang Lu, and Jing-Yu Qi, and Fan Yang, and Da-Ke Song, and Yu-Mei Wu, and Ming-Gao Zhao, and Shui-Bing Liu
February 2024, Journal of ethnopharmacology,
Yong-Li Jiang, and Xin-Shang Wang, and Xu-Bo Li, and An Liu, and Qing-Yu Fan, and Le Yang, and Ban Feng, and Kun Zhang, and Liang Lu, and Jing-Yu Qi, and Fan Yang, and Da-Ke Song, and Yu-Mei Wu, and Ming-Gao Zhao, and Shui-Bing Liu
January 2023, European journal of pharmacology,
Yong-Li Jiang, and Xin-Shang Wang, and Xu-Bo Li, and An Liu, and Qing-Yu Fan, and Le Yang, and Ban Feng, and Kun Zhang, and Liang Lu, and Jing-Yu Qi, and Fan Yang, and Da-Ke Song, and Yu-Mei Wu, and Ming-Gao Zhao, and Shui-Bing Liu
December 2023, Molecular neurobiology,
Yong-Li Jiang, and Xin-Shang Wang, and Xu-Bo Li, and An Liu, and Qing-Yu Fan, and Le Yang, and Ban Feng, and Kun Zhang, and Liang Lu, and Jing-Yu Qi, and Fan Yang, and Da-Ke Song, and Yu-Mei Wu, and Ming-Gao Zhao, and Shui-Bing Liu
October 2021, European journal of pharmacology,
Copied contents to your clipboard!